Nephrogenic diabetes insipidus: treat with caution

Area of Science:

• Nephrology
• Pediatric Endocrinology
• Clinical Case Studies

Background:

• Congenital nephrogenic diabetes insipidus (cNDI) is a rare genetic disorder characterized by the kidneys' inability to respond to antidiuretic hormone, leading to excessive thirst and urination.
• Current management strategies for cNDI involve meticulous fluid management, dietary modifications (low sodium), and pharmacotherapy, often combining thiazide diuretics with prostaglandin inhibitors or amiloride to reduce urine output.

Observation:

• A case of cNDI presented with paradoxical water intoxication, a potentially life-threatening condition.
• This complication arose secondary to excessive water intake in conjunction with the initiation of a therapeutic regimen involving hydrochlorothiazide and indomethacin.

Findings:

• The combination therapy of hydrochlorothiazide and indomethacin, while aimed at reducing urine output in cNDI, can precipitate severe water intoxication if water intake is not strictly controlled.
• This case underscores the critical need for vigilant monitoring of water balance in patients with cNDI, especially when initiating or adjusting diuretic and prostaglandin inhibitor therapies.

Implications:

• Healthcare providers must implement strict protocols for monitoring fluid balance and electrolyte levels in cNDI patients undergoing treatment with hydrochlorothiazide and indomethacin.
• Prompt recognition and intervention are crucial to manage and prevent severe complications like water intoxication in cNDI.
• This case highlights the importance of individualized treatment adjustments and close patient monitoring in managing rare genetic kidney disorders.